Childhood body mass index and adult pro-inflammatory and pro-thrombotic risk factors: Data from the New Delhi birth cohort

International Journal of Epidemiology

Volumn 40, Issue 1, 2011, Pages 102-111

  Lakshmy, Ramakrishnan ^a   Fall, Caroline H D ^b   Sachdev, Harshpal Singh ^c   Osmond, Clive ^b   Prabhakaran, Dorairaj ^d   Biswas, Sushant Dey ^e   Tandon, Nikhil ^a   Ramji, Siddharth ^f   Reddy, Kolli Srinath ^g   Barker, David J P ^b   Bhargava, Santosh K ^h  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^c SITARAM BHARTIA INSTITUTE OF SCIENCE AND RESEARCH   (India)

^d CENTRE FOR CHRONIC DISEASE CONTROL   (India)

^e INDIAN COUNCIL OF MEDICAL RESEARCH   (India)

^f MAULANA AZAD MEDICAL COLLEGE   (India)

^g PUBLIC HEALTH FOUNDATION OF INDIA   (India)

^h Sunder Lal Jain Hospital   (India)

Author keywords

Activator inhibitor 1; Birth weight; C reactive protein; Fibrinogen; Growth; Plasminogen

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; FIBRINOGEN; PLASMINOGEN ACTIVATOR INHIBITOR 1;

AGE STRUCTURE; BODY MASS; CARDIOVASCULAR DISEASE; CHILD HEALTH; COHORT ANALYSIS; PROTEIN; RISK FACTOR; WOMENS HEALTH;

ADOLESCENT; ADULT; ADULTHOOD; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CHILD; CHILDHOOD; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; INDIA; INFANCY; MAJOR CLINICAL STUDY; MALE; OBESITY; POPULATION RISK; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; THROMBOSIS; WEIGHT GAIN;

ADIPOSITY; ADOLESCENT; ADULT; BIOLOGICAL MARKERS; BODY MASS INDEX; C-REACTIVE PROTEIN; CHILD; COHORT STUDIES; FEMALE; FIBRINOGEN; HUMANS; INDIA; INFLAMMATION; MALE; PLASMINOGEN ACTIVATOR INHIBITOR 1; QUESTIONNAIRES; RISK FACTORS; THROMBOSIS;

DELHI; INDIA; NEW DELHI;

EID: 79952062482     PISSN: 03005771     EISSN: 14643685     Source Type: Journal    
DOI: 10.1093/ije/dyq121     Document Type: Article

References (47)

1. Ghaffar AA, Reddy KS, Singhi M. Burden of non-communicable diseases in South Asia. Br Med J 2004;328: 807-10.
2. Unwin N, Gan D, Whiting D. The IDF diabetes atlas: providing evidence, raising awareness and promoting action. Diabetes Res Clin Pract 2010;87:2-3.
3. Esmon CT. The interactions between inflammation and coagulation. Br J Haematol 2005;131:417-30.
4. Danesh J, Wheeler JG, Hirschfield GM et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 2004;350:1387-97.
5. Casas JP, Shah T, Hingorani AD, Danesh J, Pepys MB. C-reactive protein and coronary heart disease; a critical review. J Intern Med 2008;264:295-314.
6. Fibrinogen Studies Collaboration. Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA 2005;294:1799-809.
7. Danesh J, Collins R, Appleby P, Peto R. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease; meta-analyses of prospective studies. JAMA 1998;279:1477-82.
8. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 2001; 286:327-34.
9. Barzilay JI, Abraham L, Heckbert SR et al. The relation of markers of inflammation to the development of glucose disorders in the elderly: the Cardiovascular Health Study. Diabetes 2001;50:2384-89.
10. Freeman DJ, Norrie J, Caslake MJ et al. West of Scotland Coronary Prevention Study. C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study. Diabetes 2002;51: 1596-600.
11. Lowe GDO, Danesh J, Lewington S et al. Tissue plasmino-gen activator antigen and coronary heart disease. Eur Heart J 2004;25:252-59.
12. Ridker PM, Brown NJ, Vaughan DE, Harrison DG, Mehta JL. Established and emerging plasma biomarkers in the prediction of first atherothrombotic events. Circulation 2004;109(Suppl 1):IV6-19.
13. Forouhi NG, Sattar N. CVD risk factors and ethnicity - a homogeneous relationship? Atheroscl Supplements 2006;7: 11-19.
14. Anand SS, Yusuf S, Vuksan V et al. Differences in risk factors, atherosclerosis, and cardiovascular disease between ethnic groups in Canada: the Study of Health Assessment and Risk in Ethnic groups (SHARE). Lancet 2000;356:279-84.
15. Kain K, Catto AJ, Grant PJ. Impaired fibrinolysis and increased fibrinogen levels in South Asian subjects. Atherosclerosis 2001;156:457-61.
16. Osmond C, Barker DJP, Winter PD, Fall CHD, Simmonds SJ. Early growth and death from cardiovascular disease in women. Br Med J 1993;307:1519-24.
17. Eriksson JG, Forsen T, Tuomilehto HJ, Barker DJP. Early growth and coronary heart disease in later life: longitudinal study. Br Med J 2001;322:949-53.
18. Huxley R, Owen CG, Whincup PH et al. Is birth weight a risk factor for ischemic heart disease in later life? Am J Clin Nutr 2007;85:1244-50.
19. Whincup PH, Kaye SJ, Owen CG et al. Birthweight and risk of type 2 diabetes: a quantitative systematic review of published evidence. JAMA 2008;300:2885-97.
20. Barker DJP, Meade TW, Fall CHD et al. Relation of fetal and infant growth to plasma fibrinogen and factor VII concentrations in adult life. Br Med J 1992;304:148-52.
21. Martyn CN, Meade TW, Stirling Y, Barker DJ. Plasma concentrations of fibrinogen and Factor VII in adult life and their relation to intra-uterine growth. Br J Haematol 1995;89:142-46.
22. Nazmi A, Gonzalez DC, Oliveira IO, Horta BL, Gigante DP, Victora C. Life course weight gain and C-reactive protein levels in young adults: findings from a Brazilian birth cohort. Am J Hum Biol 2009;21:192-99.
23. Fraser A, Hughes R, McCarthy A et al. Early life growth and hemostatic factors; the Barry Caerphilly Study. Am J Epidemiol 2008;168:179-87.
24. Sattar N, McConnachie A, O'Reilly D et al. Inverse association between birth weight and C-reactive protein concentrations in the MIDSPAN family study. Arterioscler Thromb Vas Biol 2004;24:583-87.
25. Tzoulaki I, Jarvelin M-R, Hartikainen A-L et al. Size at birth, weight gain over the life course, and low-grade inflammation in young adulthood: northern Finland 1966 birth cohort study. Eur Heart J 2008;29:1049-56.
26. Byberg L, McKeigue P, Zethelius B, Lithell HO. Birthweight and the insulin resistance syndrome; association of low birthweight with truncal obesity and raised plasminogen activator inhibitor-1 but not with abdominal obesity or plasma lipid disturbances. Diabetologia 2000;43: 54-60.
27. Bhargava SK, Sachdev HPS, Fall CHD et al. Relation of serial changes in childhood body mass index to impaired glucose tolerance in young adulthood. New Eng J Med 2004;350:865-75.
28. Sachdev HPS, Fall CHD, Osmond C et al. Anthropometric indicators of body composition in young adults: relation to size at birth and serial measurements of body mass index in childhood; the New Delhi birth cohort. Am J Clin Nutr 2005;82:456-66.
29. Fall CHD, Sachdev HPS, Osmond C et al. Adult metabolic syndrome and impaired glucose tolerance are associated with different patterns of body mass index gain during infancy; data from the New Delhi birth cohort. Diabetes Care 2008;31:2349-56.
30. World Health Organization. Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications. Report of a WHO Consultation. WHO/NCD/NCS/99.2. Geneva: World Health Organization, 1999.
31. National Cholesterol Education Program. Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults. 3rd report of the National Cholesterol Education Program (NCEP) (Adult treatment panel III). JAMA 2001;285:2486-97.
32. Grundy S. Metabolic syndrome scientific statement by the American Heart Association and the National Heart, Lung, and Blood Institute. Arterioscler Thromb Vasc Biol 2005;25:2243-44.
33. Von Clauss A. Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens. Acta Haematol 1957;17: 237-46.
34. Gale CR, O'Callaghan FJ, Bredow M, Martyn CN. the ALSPAC Study Team. The influence of head growth in fetal life, infancy and childhood on intelligence at the ages of 4 and 8 years. Pediatrics 2006;118:1486.
35. Adair LS, Martorell R, Stein AD et al. Size at birth, weight gain in infancy and childhood, and adult blood pressure in five low and middle income country cohorts: when does weight gain matter? AJCN 2009;89:1383-92.
36. Pellanda LC, Duncan BB, Vigo A et al. Low birthweight and indicators of inflammation and endothelial activation in adulthood; the ARIC study. Int J Cardiol 2009;134: 371-77.
37. Frankel S, Elwood P, Sweetnam P, Yarnell J, Smith GD. Birthweight, adult risk factors and incident coronary heart disease: the Caerphilly Study. Public Health 1996; 110:139-43.
38. Fall CHD, Osmond C, Barker DJP et al. Fetal and infant growth and cardiovascular risk factors in women. Br Med J 1995;310:428-32.
39. Tuya C, Mutch WJ, Broom I, Mcneill G. The effect of birthweight on clottable and intact fibrinogen; a twin study. J Thromb Hemostasis 2005;3:1143-48.
40. Henry JA, Bolla M, Osmond C, Fall C, Barker DJ, Humphries SE. The effects of genotype and infant weight on plasma levels of fibrinogen, factor VII and LDL-cholesterol are additive. Br Med J 1997;34:553-58.
41. Naran Chetty N, Crowther NJ. The influence of metabolic syndrome components on plasma PAI-1 concentrations is modified by the PAI-1 4G/5G genotype and ethnicity. Atherosclerosis 2008;196:155-63.
42. Trevisanuto D, Doglioni N, Ainier S, Zaninotto M, Plebani M, Zanardo V. High sensitivity C-reactive protein in umbilical cord of small-for-gestational-age neonates. Neontatology 2007;91:186-89.
43. Briana DD, Malamitsi-Puchner A. Intrauterine growth restriction and adult disease: the role of adipocytokines. Eur J Endocrin 2009;160:337-47.
44. Danese A, Pariante CM, Caspi A, Taylor A, Poulton R. Childhood maltreatment predicts adult inflammation in a life-course study. Proc Natl Acad Sci USA 2007;104: 1319-24.
45. Duncan BB, Schmidt MI, Chambless LE et al. Fibrinogen, other putative markers of inflammation, and weight gain in middle-aged adults; the ARIC Study. Obesity Res 2000;8: 279-86.
46. Engstrom G, Hedblad G, Stavenow L, Lind P, Janzon L, Lindgarde F. Inflammation-sensitive plasma proteins are associated with future weight gain. Diabetes 2003;52: 2097-101.
47. Forsen T, Eriksson JG, Tuomilehto J, Osmond C, Barker DJP. Growth in utero and during childhood among women who develop coronary heart disease: longitudinal study. Br Med J 1999;319:1403-7.